Cargando…

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis

Detalles Bibliográficos
Autores principales: Thakkar, Disha, Dash, Ranjeet Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404796/
https://www.ncbi.nlm.nih.gov/pubmed/28461740
http://dx.doi.org/10.2147/DDDT.S137116
_version_ 1783231650846474240
author Thakkar, Disha
Dash, Ranjeet Prasad
author_facet Thakkar, Disha
Dash, Ranjeet Prasad
author_sort Thakkar, Disha
collection PubMed
description
format Online
Article
Text
id pubmed-5404796
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-54047962017-05-01 Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis Thakkar, Disha Dash, Ranjeet Prasad Drug Des Devel Ther Letter Dove Medical Press 2017-04-20 /pmc/articles/PMC5404796/ /pubmed/28461740 http://dx.doi.org/10.2147/DDDT.S137116 Text en © 2017 Thakkar and Dash. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Letter
Thakkar, Disha
Dash, Ranjeet Prasad
Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
title Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
title_full Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
title_fullStr Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
title_full_unstemmed Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
title_short Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
title_sort pharmacokinetic interactions between glimepiride and rosuvastatin in healthy korean subjects: does the slco1b1 or cyp2c9 genetic polymorphism affect these drug interactions? observations and introspection of the bioanalysis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404796/
https://www.ncbi.nlm.nih.gov/pubmed/28461740
http://dx.doi.org/10.2147/DDDT.S137116
work_keys_str_mv AT thakkardisha pharmacokineticinteractionsbetweenglimepirideandrosuvastatininhealthykoreansubjectsdoestheslco1b1orcyp2c9geneticpolymorphismaffectthesedruginteractionsobservationsandintrospectionofthebioanalysis
AT dashranjeetprasad pharmacokineticinteractionsbetweenglimepirideandrosuvastatininhealthykoreansubjectsdoestheslco1b1orcyp2c9geneticpolymorphismaffectthesedruginteractionsobservationsandintrospectionofthebioanalysis